Top-News
Pharmazeutika USA

Pacira Biosciences Inc News

Aktie
WKN:  A1H68T ISIN:  US6951271005 US-Symbol:  PCRX
13,00 €
-0,20 €
-1,52%
18.09.24
Handeln Depot/Watchlist
Aktienanzahl *
46,55 Mio.
Marktkapitalisierung *
612,63 Mio. €
Streubesitz
-18,36%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.07.2024

Pacira Biosciences Inc News

21.03.24 - PR Newswire
Thinking about buying stock in Healthequity, Pacira Biosciences, Interpublic Group of Companies, SIGA Technologies, or Sensus Healthcare?
Thinking about buying stock in Healthequity, Pacira Biosciences, Interpublic Group of Companies, SIGA Technologies, or Sensus Healthcare? PR Newswire
01.02.24 - PR Newswire
G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams
G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams PR Newswire
17.11.22 - PR Newswire
New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients
New Research Reveals Common Treatments for Knee Pain are Falling Short, Placing Physical, Social, and Mental Burden on Patients PR Newswire
16.06.22 - PR Newswire
National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse
National Safety Council and Pacira BioSciences Partner to Launch an Employee-​Based Program Focused on Opioid Use and Misuse PR Newswire
25.05.22 - PR Newswire
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance PR Newswire
02.11.21 - PR Newswire
FLEXION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flexion Therapeutics, Inc. - FLXN
FLEXION THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
11.10.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Flexion Therapeutics, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Flexion Therapeutics, Inc. PR Newswire
20.04.21 - PR Newswire
Spine BioPharma Announces Investment by Pacira Biosciences
Spine BioPharma Announces Investment by Pacira Biosciences Supports Clinical Advancement of Remedisc™ for Degenerative Disc Disease PR Newswire
29.11.17 - PR Newswire
Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use
Cancer Treatment Centers of America® Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opioid Use PR ...
25.01.17 - PR Newswire
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
DePuy Synthes Announces Exclusive Co-​Promotional Agreement with Pacira Pharmaceuticals, Inc. EXPAREL® Provides Orthopaedic Patients Long-​Lasting, Non-​Opioid ...
24.09.15 - The Motley Fool
Die am schnellsten wachsenden Biotechaktien
Selbst nach der ersten Korrektur seit vier Jahren lassen Biotechaktien den S&P 500 weit hinter sich. Der börsengehandelte Fonds SPDR S&P Biotech hat in den letzten fünf Jahren ...
14.07.15 - PR Newswire
Aratana Therapeutics Announces Positive Pivotal Results for AT-003
Aratana Therapeutics Announces Positive Pivotal Results for AT-003 Commercialization anticipated in 2016 PR Newswire
07.04.14 - PR Newswire
CorMedix Inc. Welcomes Additional Board Members
CorMedix Inc. Welcomes Additional Board Members PR Newswire
03.07.12 - Aktiencheck
Pacira Pharma-Aktie: in der Gunst der Anleger - Global Biotech Investing
Nach Ansicht der Experten von "Global Biotech Investing" sind spekulative Investoren bei der Rally der Aktie von Pacira Pharma stoppgesichert mit dabei. Das Unternehmen verfüge ...
17.03.11 - Aktiencheck
Pacira Pharmaceuticals "buy" - Brean Murray, Carret & Co
Rating-​Update: New York (aktiencheck.de AG) - Die Analysten von Brean Murray, Carret & Co stufen die Aktie von Pacira Pharmaceuticals in einer Ersteinschätzung mit dem Rating ...
16.03.11 - Aktiencheck
Pacira Pharmaceuticals "outperform" - Wedbush Morgan Securities
Rating-​Update: Los Angeles (aktiencheck.de AG) - Die Analysten von Wedbush Morgan Securities stufen die Aktie von Pacira Pharmaceuticals in einer Ersteinschätzung mit ...

Newssuche

Videos

newspaper
17.09.24 +2,86%
Technical Trading: 79,2 Trefferquote bei diesem Trade
S&P 500 Short Typ: Turbo Open End WKN: JK39CB Hebel: 5,28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Spark Energy Minerals
Spark Energy Minerals Inc
0,092 €
-3,16%
Spark Energy Minerals Inc Chart
Das beste Lithium-Investment aller Zeiten?!
Mehr zur Aktie »